Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-ALA/SFC to enable glucocorticoid reduction in adult-onset Still's disease
jRCTs071190042Completed
- Sponsor
- Neopharma Japan
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of 5-aminolevulinic acid hydrochloride + sodium ferrous citrate in adult-onset Still's disease (AOSD), sponsored by Neopharma Japan. Started Feb 2020; status: completed.
02
Drugs
5-aminolevulinic acid hydrochloride + sodium ferrous citrate
03
Conditions
adult-onset Still's disease (AOSD)
Beyond the preview
Go deeper on jRCTs071190042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071190042.